blogdestroyer.com
Swiss pharma giant Novartis just made a risky $9.7 billion bet on a new kind of heart drug
Novartis’ $9.7 billion acquisition of The Medicines Company, which the companies announced Sunday after days of rumors, is a story of second acts. It represents a new chance for a type of cho…